Literature DB >> 3037531

Molecular cloning of the akt oncogene and its human homologues AKT1 and AKT2: amplification of AKT1 in a primary human gastric adenocarcinoma.

S P Staal.   

Abstract

A previous report described the isolation of a directly transforming retrovirus, AKT8, from a spontaneous thymoma of an AKR mouse. The AKT8 provirus has now been molecularly cloned from a transformed, nonproducer cell line. The virus genome contains both viral and nonviral, cell-related sequences; the nonviral sequence has been designated v-akt, the presumed viral oncogene of the AKT8 virus. This gene lacks homology to the 16 other oncogenes tested. The cloned provirus has undergone a partial deletion, during cell passage in vitro, that prevents direct demonstration of the transforming ability of this molecular clone. Two human homologues of the v-akt oncogene, AKT1 and AKT2, were cloned. A survey of 225 human tumors for changes involving AKT1 led to the discovery of a 20-fold amplification of this gene in one of the five gastric adenocarcinomas tested. The results demonstrate that AKT8 has the characteristic structure of a directly transforming retrovirus and that it contains a gene derived from highly conserved cellular sequences that may be involved in the pathogenesis of some human malignancies.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3037531      PMCID: PMC305241          DOI: 10.1073/pnas.84.14.5034

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  19 in total

1.  Leukemia virus genomes in the chromosomal DNA of the mouse.

Authors:  W P Rowe
Journal:  Harvey Lect       Date:  1978

2.  Detection of specific sequences among DNA fragments separated by gel electrophoresis.

Authors:  E M Southern
Journal:  J Mol Biol       Date:  1975-11-05       Impact factor: 5.469

3.  Efficeint transcription of RNA into DNA by avian sarcoma virus polymerase.

Authors:  J M Taylor; R Illmensee; J Summers
Journal:  Biochim Biophys Acta       Date:  1976-09-06

4.  Murine leukemia virus (T-8)-transformed cells: identification of a precursor polyprotein containing gag gene-coded proteins (p15 and p12) and a nonstructural component.

Authors:  T L Sacks; F H Reynolds; D N Deobagkar; J R Stephenson
Journal:  J Virol       Date:  1978-09       Impact factor: 5.103

5.  Construction and characterization of the hybrid bacteriophage lambda Charon vectors for DNA cloning.

Authors:  B G Williams; F R Blattner
Journal:  J Virol       Date:  1979-02       Impact factor: 5.103

6.  Restriction endonuclease mapping of ecotropic murine leukemia viral DNAs: size and sequence heterogeneity of the long terminal repeat.

Authors:  E Rands; D R Lowy; M R Lander; S K Chattopadhyay
Journal:  Virology       Date:  1981-01-30       Impact factor: 3.616

7.  Mapping of heavy chain genes for mouse immunoglobulins M and D.

Authors:  C P Liu; P W Tucker; J F Mushinski; F R Blattner
Journal:  Science       Date:  1980-09-19       Impact factor: 47.728

8.  Molecular cloning of infectious integrated murine leukemia virus DNA from infected mouse cells.

Authors:  D R Lowy; E Rands; S K Chattopadhyay; C F Garon; G L Hager
Journal:  Proc Natl Acad Sci U S A       Date:  1980-01       Impact factor: 11.205

9.  Isolation of transforming murine leukemia viruses from mice with a high incidence of spontaneous lymphoma.

Authors:  S P Staal; J W Hartley; W P Rowe
Journal:  Proc Natl Acad Sci U S A       Date:  1977-07       Impact factor: 11.205

10.  Insertion of synthetic copies of human globin genes into bacterial plasmids.

Authors:  J T Wilson; L B Wilson; J K deRiel; L Villa-komaroff; A Efstratiadis; B G Forget; S M Weissman
Journal:  Nucleic Acids Res       Date:  1978-02       Impact factor: 16.971

View more
  207 in total

1.  Latent membrane protein 2A-mediated effects on the phosphatidylinositol 3-Kinase/Akt pathway.

Authors:  R Swart; I K Ruf; J Sample; R Longnecker
Journal:  J Virol       Date:  2000-11       Impact factor: 5.103

Review 2.  AKT plays a central role in tumorigenesis.

Authors:  J R Testa; A Bellacosa
Journal:  Proc Natl Acad Sci U S A       Date:  2001-09-25       Impact factor: 11.205

Review 3.  Gastric carcinogenesis: diet as a causative factor.

Authors:  T Sugimura; K Wakabayashi
Journal:  Med Oncol Tumor Pharmacother       Date:  1990

4.  Involvement of FKHR-dependent TRADD expression in chemotherapeutic drug-induced apoptosis.

Authors:  Susumu Rokudai; Naoya Fujita; Osamu Kitahara; Yusuke Nakamura; Takashi Tsuruo
Journal:  Mol Cell Biol       Date:  2002-12       Impact factor: 4.272

5.  Attenuation of TORC1 signaling delays replicative and oncogenic RAS-induced senescence.

Authors:  Marina Kolesnichenko; Lixin Hong; Rong Liao; Peter K Vogt; Peiqing Sun
Journal:  Cell Cycle       Date:  2012-06-15       Impact factor: 4.534

Review 6.  Oncogenic mutations of PIK3CA in human cancers.

Authors:  Yardena Samuels; Todd Waldman
Journal:  Curr Top Microbiol Immunol       Date:  2010       Impact factor: 4.291

Review 7.  Programmed cell death pathways in cancer: a review of apoptosis, autophagy and programmed necrosis.

Authors:  L Ouyang; Z Shi; S Zhao; F-T Wang; T-T Zhou; B Liu; J-K Bao
Journal:  Cell Prolif       Date:  2012-10-03       Impact factor: 6.831

8.  Non-peptidic substrate-mimetic inhibitors of Akt as potential anti-cancer agents.

Authors:  Katherine J Kayser-Bricker; Matthew P Glenn; Sang Hoon Lee; Said M Sebti; Jin Q Cheng; Andrew D Hamilton
Journal:  Bioorg Med Chem       Date:  2008-09-27       Impact factor: 3.641

Review 9.  The PIK3CA gene as a mutated target for cancer therapy.

Authors:  John P Gustin; David P Cosgrove; Ben Ho Park
Journal:  Curr Cancer Drug Targets       Date:  2008-12       Impact factor: 3.428

10.  1H, 15N and 13C chemical shift assignments of the Pleckstrin Homology domain of the Human Protein Kinase B (PKB/Akt).

Authors:  Daniel Auguin; Philippe Barthe; Marie-Thérèse Augé-Sénégas; François Hoh; Masayuki Noguchi; Christian Roumestand
Journal:  J Biomol NMR       Date:  2003-11       Impact factor: 2.835

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.